Source: BioPharm

Micro-macinazione: Lonza Boosts Micronization Capacity with Acquisition

On August 4, 2017, Lonza announced that it acquired Micro-Macinazione (Switzerland), a contract manufacturer providing micronization of active ingredients for the pharmaceutical and fine chemical industries, from Cross Equity, a Swiss private equity firm. The acquisition was completed on July 26

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Markus Arigoni's photo - CEO of Micro-macinazione

CEO

Markus Arigoni

CEO Approval Rating

70/100

Read more